Location History:
- Nobeoka, JA (1976)
- Fuji, JP (1985)
Company Filing History:
Years Active: 1976-1985
Title: Hiroshige Kojima: Innovator in Biotechnology
Introduction
Hiroshige Kojima is a notable inventor based in Nobeoka, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of processes related to plasminogen activators and aquaculture feeds. With a total of 2 patents, his work has implications for both medical and agricultural industries.
Latest Patents
Kojima's latest patents include a process for the preparation of a plasminogen activator. This process involves bringing normal diploid cells derived from human bodies, which are capable of producing the plasminogen activator, into contact with a solution containing enzymatically-decomposed animal meat peptone. The plasminogen activator produced has specific properties that are beneficial for various applications. Another significant patent is related to a feed for aquianimals cultivation. This feed comprises a culture product of strains of marine or halophilic yeasts, specifically designed to optimize the growth of aquaculture species such as Brachionus, Copepoda, Brine Shrimp, and various stages of shrimp larvae.
Career Highlights
Kojima is currently associated with Asahi Kasei Kogyo Kabushiki Kaisha, where he continues to innovate and develop new biotechnological solutions. His work has been instrumental in advancing the understanding and application of biotechnology in both medical and agricultural fields.
Collaborations
Throughout his career, Kojima has collaborated with notable colleagues, including Takatsugu Kawano and Hiroshi Ohosawa. These collaborations have further enriched his research and development efforts.
Conclusion
Hiroshige Kojima's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact both the medical and aquaculture industries, showcasing the importance of innovation in addressing contemporary challenges.